M J Zelefsky

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models
    S Levegrun
    Department Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 47:1245-60. 2000
  2. ncbi request reprint Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms
    A Jackson
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 49:685-98. 2001
  3. doi request reprint Biochemical response to androgen deprivation therapy before external beam radiation therapy predicts long-term prostate cancer survival outcomes
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 86:529-33. 2013
  4. doi request reprint Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    BJU Int 110:1696-701. 2012
  5. ncbi request reprint Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes
    Michael J Zelefsky
    Departments of Radiation Oncology, Medical Physics, and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Eur Urol 60:1133-9. 2011
  6. doi request reprint How to select the optimal therapy for early-stage prostate cancer
    Marisa A Kollmeier
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
    Crit Rev Oncol Hematol 84:e6-e15. 2012
  7. pmc Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapy
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Brachytherapy 12:19-24. 2013
  8. doi request reprint Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 84:125-9. 2012
  9. doi request reprint Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Brachytherapy 11:245-9. 2012
  10. doi request reprint Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 83:953-9. 2012

Detail Information

Publications106 found, 100 shown here

  1. ncbi request reprint Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models
    S Levegrun
    Department Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 47:1245-60. 2000
    ..To investigate tumor control following three-dimensional conformal radiation therapy (3D-CRT) of prostate cancer and to identify dose-distribution variables that correlate with local control assessed through posttreatment prostate biopsies...
  2. ncbi request reprint Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms
    A Jackson
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 49:685-98. 2001
    ..The purpose of this study is to identify features of the cumulative dose-volume histogram (DVH) for the rectal wall that correlate with late rectal bleeding after 3D-CRT for prostate cancer...
  3. doi request reprint Biochemical response to androgen deprivation therapy before external beam radiation therapy predicts long-term prostate cancer survival outcomes
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 86:529-33. 2013
    ....
  4. doi request reprint Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    BJU Int 110:1696-701. 2012
    ..In this report we also note that even among patients who develop second cancers, if detected earlier, the majority are alive 5 years after the diagnosis...
  5. ncbi request reprint Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes
    Michael J Zelefsky
    Departments of Radiation Oncology, Medical Physics, and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Eur Urol 60:1133-9. 2011
    ..Higher radiation dose levels have been shown to be associated with improved tumor-control outcomes in localized prostate cancer (PCa) patients...
  6. doi request reprint How to select the optimal therapy for early-stage prostate cancer
    Marisa A Kollmeier
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
    Crit Rev Oncol Hematol 84:e6-e15. 2012
    ..This review will discuss the relevant issues in the decision making and treatment selection for the patient...
  7. pmc Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapy
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Brachytherapy 12:19-24. 2013
    ..We report on quality of dose delivery to target and normal tissues from low-dose-rate prostate brachytherapy using postimplantation dosimetric evaluations from a random sample of U.S. patients...
  8. doi request reprint Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 84:125-9. 2012
    ..To compare toxicity profiles and biochemical tumor control outcomes between patients treated with high-dose image-guided radiotherapy (IGRT) and high-dose intensity-modulated radiotherapy (IMRT) for clinically localized prostate cancer...
  9. doi request reprint Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Brachytherapy 11:245-9. 2012
    ..To identify predictors of biochemical tumor control and present an updated prognostic nomogram for patients with clinically localized prostate cancer treated with brachytherapy...
  10. doi request reprint Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 83:953-9. 2012
    ..To report the incidence and excess risk of second malignancy (SM) development compared with the general population after external beam radiotherapy (EBRT) and brachytherapy to treat prostate cancer...
  11. ncbi request reprint Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 82:1744-8. 2012
    ..To report tumor local progression-free outcomes after treatment with single-dose, image-guided, intensity-modulated radiotherapy and hypofractionated regimens for extracranial metastases from renal cell primary tumors...
  12. doi request reprint Real-time intraoperative computed tomography assessment of quality of permanent interstitial seed implantation for prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Brachytherapy Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Urology 76:1138-42. 2010
    ..To evaluate the use of real-time kilovoltage cone-beam computed tomography (CBCT) during prostate brachytherapy for intraoperative dosimetric assessment and correcting deficient dose regions...
  13. ncbi request reprint Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Clin Oncol 23:826-31. 2005
    ..To identify predictors of distant metastases (DM) among patients who develop an isolated prostate-specific antigen (PSA) relapse after definitive external-beam radiotherapy for clinically localized prostate cancer...
  14. ncbi request reprint Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 55:956-63. 2003
    ..We report the preliminary outcome of patients with localized prostate cancer treated with this approach...
  15. ncbi request reprint Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 59:1053-61. 2004
    ..To report changing trends in external beam radiotherapy (EBRT) delivery practice for clinically localized prostate cancer as determined from the 1999 survey from the American College of Radiology National Patterns of Care Study...
  16. doi request reprint Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 75:1350-6. 2009
    ..To report the influence of posttreatment prostate-specific antigen (PSA) nadir response at 2 years after external beam radiotherapy (RT) on distant metastases (DM) and cause-specific mortality (CSM)...
  17. ncbi request reprint Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Urology 77:986-90. 2011
    ..To compare the long-term, prostate-specific antigen relapse-free survival outcome and incidence of toxicity for patients with low-risk prostate cancer who underwent brachytherapy or intensity-modulated radiotherapy (RT)...
  18. ncbi request reprint Intensity-modulated radiation therapy for prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Radiat Oncol 12:229-37. 2002
    ..Clinical trials will be necessary to define more clearly the true extent of improved tumor control and reduction in normal tissue complications with IMRT in the treatment of prostate cancer...
  19. ncbi request reprint Three-dimensional conformal brachytherapy for prostate cancer
    Michael J Zelefsky
    Brachytherapy Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Curr Urol Rep 5:173-8. 2004
    ..Such approaches will minimize the possibility of tumor underdosage and further enhance the conformality of prostate brachytherapy...
  20. doi request reprint Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 70:1124-9. 2008
    ..To report the incidence and predictors of treatment-related toxicity at 10 years after three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT) for localized prostate cancer...
  21. ncbi request reprint High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 53:1111-6. 2002
    ..To report the acute and late toxicity and preliminary biochemical outcomes in 772 patients with clinically localized prostate cancer treated with high-dose intensity-modulated radiotherapy (IMRT)...
  22. doi request reprint Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Brachytherapy 7:1-6. 2008
    ....
  23. pmc Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Clin Oncol 28:1508-13. 2010
    ..We assessed the effect of radical prostatectomy (RP) and external beam radiotherapy (EBRT) on distant metastases (DM) rates in patients with localized prostate cancer treated with RP or EBRT at a single specialized cancer center...
  24. ncbi request reprint Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 67:65-70. 2007
    ..To report the 5-year tumor control and toxicity outcomes for patients with localized prostate treated with I-125 permanent implantation using an intraoperative real-time conformal planning technique...
  25. ncbi request reprint Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy
    M J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021 6007, USA
    J Clin Oncol 16:3380-5. 1998
    ....
  26. ncbi request reprint Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY10021, USA
    Radiother Oncol 84:185-9. 2007
    ..To report the dosimetric outcome of patients with clinically localized prostate cancer treated with I-125 permanent implantation using an intraoperative real-time conformal planning technique...
  27. ncbi request reprint PSA bounce versus biochemical failure following prostate brachytherapy
    Michael J Zelefsky
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10024, USA
    Nat Clin Pract Urol 3:578-9. 2006
  28. ncbi request reprint Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer
    M J Zelefsky
    Department of Radiation Oncology, Solid Tumor Service, Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 18:1936-41. 2000
    ..To assess the feasibility and tolerance of neoadjuvant and concomitant estramustine phosphate and vinblastine (EV) with high-dose three-dimensional conformal radiotherapy (3D-CRT) for patients with unfavorable-risk prostate cancer...
  29. ncbi request reprint Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 67:327-33. 2007
    ..To assess long-term prostate-specific antigen (PSA) outcome after permanent prostate brachytherapy (BT) and identify predictors of improved disease-free survival...
  30. ncbi request reprint Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 176:1415-9. 2006
    ..We report on the long-term results and late toxicity outcomes of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer...
  31. ncbi request reprint Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer
    M J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 47:1261-6. 2000
    ....
  32. ncbi request reprint Evaluation of postradiotherapy PSA patterns and correlation with 10-year disease free survival outcomes for prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 66:382-8. 2006
    ....
  33. ncbi request reprint Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Urology 70:283-7. 2007
    ....
  34. ncbi request reprint Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique
    M J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 48:601-8. 2000
    ..To compare the target coverage and dose to normal tissues after I-125 transperineal permanent implantation (TPI) of the prostate in 90 patients treated with one of three different transperineal techniques...
  35. doi request reprint Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 71:1028-33. 2008
    ..To report prostate-specific antigen (PSA) relapse-free survival and distant metastases-free survival (DMFS) outcomes for patients with clinically localized prostate cancer treated with high-dose conformal radiotherapy...
  36. doi request reprint Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Eur Urol 53:1172-9. 2008
    ..To report the long-term tumor control and survival outcomes after conformal external-beam radiotherapy for patients with clinical stage T3 prostate cancer...
  37. pmc Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 179:1368-73; discussion 1373. 2008
    ..In addition, we report the influence of local tumor control on long-term distant metastases and cause specific survival outcomes...
  38. ncbi request reprint Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response
    M W Skwarchuk
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    Int J Radiat Oncol Biol Phys 47:103-13. 2000
    ....
  39. ncbi request reprint Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma
    S L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 19:1105-10. 2001
    ..To evaluate the feasibility and efficacy of concomitant boost radiotherapy (RT) plus cisplatin-based chemotherapy compared with standard fractionation RT for patients with advanced nasopharyngeal cancer...
  40. ncbi request reprint Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data
    S Levegrun
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 51:1064-80. 2001
    ..We discuss differences in the radiobiologic parameters and dose-response curves and demonstrate pitfalls in interpreting the results...
  41. ncbi request reprint Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging
    M Zaider
    Departments of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 47:1085-96. 2000
    ..A method is described that registers MRSI to intraoperative-obtained ultrasound images and incorporates this information into a treatment-planning system to achieve dose escalation to intraprostatic tumor deposits...
  42. ncbi request reprint Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer
    Charles J Ryan
    Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Urology 64:90-4. 2004
    ..To describe the 5-year outcomes of patients with high-risk localized prostate cancer treated with neoadjuvant estramustine and vinblastine followed by concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)...
  43. ncbi request reprint Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer
    Steven A Leibel
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Oncol 30:596-615. 2003
    ..In some patients, both approaches may be necessary to maximize the probability of cure. In view of the favorable benefit-risk ratio of high-dose IMRT, the design of clinical trials to resolve these critical questions is essential...
  44. ncbi request reprint High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer
    K M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 48:219-26. 2000
    ..This is an update of our preliminary report with longer follow-up and larger patient numbers...
  45. ncbi request reprint High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer
    M J Zelefsky
    Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Urol 166:876-81. 2001
    ..Intensity modulated radiation therapy is associated with minimal rectal and bladder toxicity, and, hence, represents the treatment delivery approach with the most favorable risk-to-benefit ratio...
  46. ncbi request reprint Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer
    S L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 46:859-64. 2000
    ..Nasopharynx cancer is a rare malignancy in childhood. This study aims to determine the role of chemotherapy, the optimal dose of radiation, and the long-term outcome for children with locoregional disease...
  47. ncbi request reprint Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer
    Matthew S Katz
    Departments of Radiation Oncology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 21:483-9. 2003
    ..To identify predictors of biochemical outcome following radiotherapy in patients with a rising prostate-specific antigen (PSA) after radical prostatectomy for prostate cancer...
  48. ncbi request reprint High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results
    Ashwatha Narayana
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Brachytherapy 6:157-63. 2007
    ..We report our preliminary results in patients with recurrent H&N cancers treated with interstitial HDRBT...
  49. ncbi request reprint Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer
    M W Kattan
    Departments of Urology, Epidemiology and Biostatistics, and Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 18:3352-9. 2000
    ..The purpose of this study was to develop a nomogram to improve the accuracy of predicting outcome after three-dimensional conformal radiotherapy...
  50. ncbi request reprint The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States
    W Robert Lee
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
    Cancer 98:1987-94. 2003
    ..The objective of the current study was to provide descriptive information on a representative national sample of patients with prostate carcinoma who were treated with prostate brachytherapy (PB) in calendar year 1999...
  51. ncbi request reprint A survival model for fractionated radiotherapy with an application to prostate cancer
    M Zaider
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Phys Med Biol 46:2745-58. 2001
    ....
  52. doi request reprint Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, New York 10021, USA
    Head Neck 30:925-32. 2008
    ....
  53. doi request reprint Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer
    Ramesh Rengan
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Clin Oncol 31:465-9. 2008
    ..To examine the long-term neck failure outcome in patients with advanced head and neck cancer treated on larynx/organ preservation protocols at Memorial Sloan-Kettering Cancer Center...
  54. ncbi request reprint Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 67:691-702. 2007
    ..To perform a retrospective analysis of patients with paranasal sinus (PNS) cancer treated with postoperative radiotherapy (RT) at Memorial Sloan-Kettering Cancer Center...
  55. ncbi request reprint Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes
    Nelson N Stone
    Mount Sinai School of Medicine, New York, NY, USA
    Int J Radiat Oncol Biol Phys 69:1472-7. 2007
    ..To investigate the biochemical control rate in patients undergoing permanent prostate brachytherapy as a function of the biologically effective dose (BED) and risk group...
  56. ncbi request reprint Intraoperative dynamic dosimetry for prostate implants
    D A Todor
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Phys Med Biol 48:1153-71. 2003
    ..To offset the effect of organ motion the comparison was performed in terms of the proximity function of the two seed distributions. The agreement between the intra- and post-operative seed distributions was excellent...
  57. ncbi request reprint Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer
    M A Hunt
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, Box 84, 1275 York Avenue, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 49:623-32. 2001
    ..To implement intensity-modulated radiation therapy (IMRT) for primary nasopharynx cancer and to compare this technique with conventional treatment methods...
  58. ncbi request reprint Morbidity of adjuvant brachytherapy in soft tissue sarcoma of the extremity and superficial trunk
    K M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 47:1273-9. 2000
    ..The purpose of this study was to evaluate the toxicity associated with adjuvant BRT in terms of wound complications, bone fracture, and peripheral nerve damage...
  59. ncbi request reprint Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy
    Michelle L Klem
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA
    Int J Radiat Oncol Biol Phys 70:1100-7. 2008
    ..With conventional techniques, significant toxicity can develop. Intensity-modulated radiotherapy (IMRT) has the potential to minimize the toxicity...
  60. pmc Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI
    Michael H Fuchsjäger
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 78:743-50. 2010
    ..To investigate whether pretreatment endorectal magnetic resonance imaging (MRI) findings can predict biochemical relapse in patients with clinically localized prostate cancer treated with external beam radiation therapy (EBRT)...
  61. pmc Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx
    Jeannette Marie S Matsuo
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg 238:412-21; discussion 421-2. 2003
    ..To determine the impact of clinical nodal stage on distant metastasis (DM) in patients with squamous cell carcinoma of the larynx (SCCL)...
  62. ncbi request reprint Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era
    Deborah A Kuban
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 57:915-28. 2003
    ..To report the long-term outcome for patients with Stage T1-T2 adenocarcinoma of the prostate definitively irradiated in the prostate-specific antigen (PSA) era...
  63. ncbi request reprint Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer
    Sabine Levegrun
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Radiother Oncol 63:11-26. 2002
    ..We fit phenomenological tumor control probability (TCP) models to biopsy outcome after three-dimensional conformal radiation therapy (3D-CRT) of prostate cancer patients to quantify the local dose-response of prostate cancer...
  64. ncbi request reprint A method of incorporating organ motion uncertainties into three-dimensional conformal treatment plans
    G S Mageras
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 35:333-42. 1996
    ..We describe a method of incorporating organ motion into three-dimensional (3D) conformal treatment plans, which predicts the effect of organ motion on the calculated dose to both the clinical target volume (CTV) and nontarget organs...
  65. doi request reprint High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer
    David J Perry
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 76:1140-6. 2010
    ..To report the use of high-dose-rate intraoperative radiation therapy (HDR-IORT) for recurrent head-and-neck cancer (HNC) at a single institution...
  66. doi request reprint Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes
    Oren Cahlon
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 71:330-7. 2008
    ..To report toxicity and preliminary biochemical outcomes with high-dose intensity-modulated radiation therapy (IMRT) to a dose of 86.4 Gy for localized prostate cancer...
  67. doi request reprint Physician visits prior to treatment for clinically localized prostate cancer
    Thomas L Jang
    Department of Surgery, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, New York, USA
    Arch Intern Med 170:440-50. 2010
    ..We evaluated how visits to specialists and primary care physicians (PCPs) by men with localized prostate cancer are related to treatment choice...
  68. ncbi request reprint Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy
    Mary Feng
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
    Int J Radiat Oncol Biol Phys 68:1417-23. 2007
    ..To determine the rate and magnitude of late genitourinary (GU) and gastrointestinal (GI) toxicities after salvage or adjuvant radiotherapy (RT) for prostate cancer, and to determine predictive factors for these toxicities...
  69. ncbi request reprint Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    JAMA 291:1325-32. 2004
    ..Salvage radiotherapy may potentially cure patients with disease recurrence after radical prostatectomy, but previous evidence has suggested that it is ineffective in patients at the highest risk of metastatic disease progression...
  70. ncbi request reprint Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer
    Gilbert D A Padula
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 52:439-43. 2002
    ....
  71. ncbi request reprint Time trends in organ position and volume in patients receiving prostate three-dimensional conformal radiotherapy
    James G Mechalakos
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Radiother Oncol 62:261-5. 2002
    ..The subset of patients undergoing hormone therapy was also tested and did not independently exhibit any significant time trends...
  72. ncbi request reprint Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Urol 170:1828-32. 2003
    ..We report the long-term prostate specific antigen relapse-free survival rates and predictors of biochemical outcome for patients 60 years or younger with prostate cancer treated with high dose conformal external beam radiotherapy...
  73. ncbi request reprint Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues
    P B Gaudin
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Am J Surg Pathol 23:1021-31. 1999
    ..The effects of 3DCRT on prostate cancer are variable, with some cases showing profound therapy-related changes and others showing no apparent therapy effect...
  74. ncbi request reprint Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma
    S L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 49:1229-34. 2001
    ..To determine whether the use of 3-dimensional (3D) boost for patients with nasopharynx cancer improves local control and reduces the risk of long-term complications...
  75. ncbi request reprint Intensity-modulated radiotherapy
    Steven A Leibel
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer J 8:164-76. 2002
    ..The implementation of biologic evaluation of tumor sensitivity, in addition to methods that improve target delineation and dose delivery, represents a new dimension in intensity-modulated radiotherapy research...
  76. ncbi request reprint Tolerance of tissue transfers to adjuvant radiation therapy in primary soft tissue sarcoma of the extremity
    Marnee M Spierer
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 56:1112-6. 2003
    ..EBRT (17% vs. 0%, p = 0.06); upper vs. lower extremity (0% vs. 8%, p = 0.41); <or=5 cm vs. >5 cm (8% vs. 4%, p = 0.9); comorbidity vs. no comorbidity (3% vs. 13%, p = 0.8); age <or=50 vs. >50 (8% vs. 4%, p = 0.8)...
  77. doi request reprint Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy
    Nelson N Stone
    Mount Sinai School of Medicine, New York, NY, USA
    Int J Radiat Oncol Biol Phys 73:341-6. 2009
    ..To investigate the biochemical control rates and survival for Gleason score 7-10 prostate cancer patients undergoing permanent prostate brachytherapy as a function of the biologic effective dose (BED)...
  78. doi request reprint Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 72:763-9. 2008
    ..To evaluate long-term outcomes and toxicity in patients with unresectable paranasal sinus carcinoma treated with radiotherapy, with or without chemotherapy...
  79. ncbi request reprint Intraoperative high-dose-rate brachytherapy for pediatric solid tumors: a 10-year experience
    Karyn A Goodman
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Brachytherapy 2:139-46. 2003
    ..To evaluate the efficacy and toxicity of intraoperative high-dose-rate brachytherapy (IOHDR) in the management of pediatric solid tumors...
  80. doi request reprint Fluoroscopically guided interventional procedures: a review of radiation effects on patients' skin and hair
    Stephen Balter
    Department of Medicine, Columbia University Medical Center, 627 W 165th St, New York, NY 10021, USA
    Radiology 254:326-41. 2010
    ..If the same area of skin is likely to be exposed to levels higher than a few grays, the effects of previous irradiation should be included when estimating the expected tissue reaction from the additional procedure...
  81. ncbi request reprint PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis
    Michael E Ray
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
    Int J Radiat Oncol Biol Phys 64:1140-50. 2006
    ....
  82. ncbi request reprint Endorectal MR imaging before salvage prostatectomy: tumor localization and staging
    Evis Sala
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Radiology 238:176-83. 2006
    ....
  83. ncbi request reprint Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure
    Michael E Ray
    Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0010, USA
    Urology 68:1257-62. 2006
    ..To determine whether nadir prostate-specific antigen (PSA) levels within 12 months (nadir PSA12) after completion of radiotherapy (RT) can be used as an early marker of recurrence risk...
  84. ncbi request reprint Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethra
    G Dalbagni
    Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    J Urol 166:1759-61. 2001
    ..Local control seems to have improved. We must evaluate a larger cohort of patients to determine this impact of the combined modality on local control and patient survival...
  85. ncbi request reprint The indications for elective treatment of the neck in cancer of the major salivary glands
    J G Armstrong
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021
    Cancer 69:615-9. 1992
    ..High-grade tumors and larger tumors have a high rate of occult neck metastases, and treatment should be considered in this group...
  86. pmc Variation in adherence to external beam radiotherapy quality measures among elderly men with localized prostate cancer
    Justin E Bekelman
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 69:1456-66. 2007
    ..S. men...
  87. ncbi request reprint Development of a semi-automatic alignment tool for accelerated localization of the prostate
    Chiaho Hua
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 55:811-24. 2003
    ..A rapid computed tomography (CT)-based online prostate localization method is presented for this purpose...
  88. ncbi request reprint The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 95:316-21. 2002
    ..The objective of this study was to determine whether the depth of myometrial invasion is correlated with outcome in patients with Stage IB endometrial carcinoma...
  89. ncbi request reprint The Anderson nomograms for permanent interstitial prostate implants: a briefing for practitioners
    Gil ad N Cohen
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 53:504-11. 2002
    ..e., patient-to-patient and planner-to-planner variability). In each case, the computer-optimization system for intraoperative planning currently in use at our institution was taken as the "gold standard."..
  90. ncbi request reprint Adjuvant brachytherapy for primary high-grade soft tissue sarcoma of the extremity
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 9:48-56. 2002
    ..We reviewed single-institution experience using brachytherapy alone for primary high-grade soft tissue sarcoma of the extremity...
  91. ncbi request reprint Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence
    Darko Pucar
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 69:62-9. 2007
    ....
  92. ncbi request reprint Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis
    Eric M Horwitz
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Cancer 107:1496-502. 2006
    ....
  93. doi request reprint Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience
    Stephanie A Terezakis
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 73:795-801. 2009
    ..External beam radiotherapy (EBRT) plays a controversial role in the management of nonanaplastic thyroid cancer. We reviewed our institution's outcomes in patients treated with EBRT for advanced or recurrent nonanaplastic thyroid cancer...
  94. ncbi request reprint Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Brachytherapy 5:157-64. 2006
    ..To report PSA relapse-free survival and toxicity outcomes of prostate cancer patients who have undergone three-dimensional computer-optimized high-dose-rate (HDR) brachytherapy with external beam radiotherapy as definitive treatment...
  95. ncbi request reprint Dosimetric and anatomic indicators of late rectal toxicity after high-dose intensity modulated radiation therapy for prostate cancer
    Reshma Munbodh
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Med Phys 35:2137-50. 2008
    ..Late rectal toxicity was related to the irradiation of the upper part of the rectum and also to the absolute area irradiated, PTV size, and rectum size on the planning computed tomography (CT) scan...
  96. ncbi request reprint Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity
    K M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 48:1051-8. 2000
    ..The purpose of this study was to determine if adjuvant RT improves local control in patients with high-grade STS who had positive margins of resection...
  97. ncbi request reprint Single-fraction intraoperative radiotherapy for breast cancer: early cosmetic results
    Kathryn Beal
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 69:19-24. 2007
    ..To evaluate the cosmetic outcome of patients treated with wide local excision and intraoperative radiotherapy for early-stage breast cancer...
  98. ncbi request reprint Assessment of radiation safety instructions to patients based on measured dose rates following prostate brachytherapy
    Lawrence T Dauer
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Brachytherapy 3:1-6. 2004
    ..To validate radiation safety instructions to patients and to evaluate the potential radiation doses to members of the public after (125)I or (103)Pd prostate implantation...
  99. ncbi request reprint Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm
    David G Pfister
    Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 24:1072-8. 2006
    ..Cetuximab has activity in squamous cell carcinoma and enhances both chemotherapy and radiotherapy. We conducted a pilot phase II study of a new combined-modality paradigm of targeted therapy (cetuximab) with chemoradiotherapy...
  100. pmc Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195 0001, USA
    J Clin Oncol 25:2035-41. 2007
    ..We developed a nomogram to predict the probability of cancer control at 6 years after SRT for PSA-defined recurrence...
  101. ncbi request reprint Adjuvant radiation for stage II-B soft tissue sarcoma of the extremity
    Kaled M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 20:1643-50. 2002
    ..This study sought to define the optimal management in patients with stage II-B (high-grade, size < or = 5 cm) tumors...